Sign inJoin waitlistJoin the waitlist

RD

Rhian Davies

Assistant Professor · DREXEL UNIVERSITY

Credentials: · · · · · · · ·

History

DREXEL UNIVERSITY
Present

Interventional Cardiology
2024–2025
Cardiovascular Disease
University of Washington Medical Center - Montlake
2021–2024
Cardiovascular Disease
Penn State Milton S Hershey Medical Center
2018–2021
Cardiovascular Disease
Rhode Island Hospital/Brown University Health
2015–2018
Internal Medicine
Penn State Milton S Hershey Medical Center
2012–2015
Philadelphia College of Osteopathic Medicine
2008–2012
Saint Joseph's University
2004–2008

Research

Predicting Periprocedural Complications in Chronic Total Occlusion Percutaneous Coronary Intervention: The PROGRESS-CTO Complication Scores
JACC: Cardiovascular Interventions · 2022 · 91 citations
Back hand approach to radial access: The snuff box approach
Case report · Cardiovascular revascularization medicine · 2018 · First of 2 authors · Corresponding · 54 citations
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the…
EuroIntervention · 2023 · 38 citations

Emmanouil Brilakis
55 papers
Khaldoon Alaswad
54 papers
JK
Jaikirshan Khatri
49 papers
Farouc Jaffer
47 papers
Yader Sandoval
46 papers
Paul Poommipanit
41 papers
Nicholas Burke
40 papers
James Choi
37 papers
Lorenzo Azzalini
35 papers
Athanasios Rempakos
34 papers · 17 as a resident
MA
Michaella Alexandrou
33 papers
Bahadir Simsek
30 papers · 30 as a fellow

Clinical trials

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2026–2029
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Site PI · Recruiting
Supira Medical
2026–2027
AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease
Site PI · Not yet recruiting
OPCI Core Laboratories LLC
2026
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Site PI · Recruiting · Phase 4
Duke University
2025–2029